Accession Number: | 0001562180-19-006144 |
Date: | 2019-12-13 |
Issuer: | PROGENICS PHARMACEUTICALS INC (PGNX) |
Original Submission Date: |
BER GERARD
UNTERE ROOSTMATT 16
CH 6300, V8 V8
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 5.01 | 2019-12-13 | deemed execution date | A | 16,393 (a) | 2019-12-13 | 2029-12-13 | common stock 16,393 | $5.01 | 16,393 | direct |
ID | footnote |
---|---|
f1 | this stock option becomes exercisable immediately on the date of grant. |